Newsroom

  • Category

  • By Date

  • Press Release

    15 March 24

    CuraTeQ Biologics successfully completes Phase 1 trial for Omalizumab biosimilar

    Read more
  • Press Release

    17 February 24

    Auro Peptides completes US FDA inspection with zero observations

    Read more
  • Press Release

    17 January 24

    CuraTeQ Biologics’ Trastuzumab Biosimilar receives recommendation for marketing authorization in India

    Read more